Dr David Goode
Honorary (Senior Fellow)
The Sir Peter MacCallum Department of Oncology
70 Scholarly works
7 Projects
HIGHLIGHTS
2026
Journal article
Putative breast cancer risk variants from populations of South Asian ancestry are under-represented in public variant classification databases
DOI: 10.1186/s13058-025-02166-82026
Journal article
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.
DOI: 10.1038/s41467-026-74334-z2025
Journal article
Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology
DOI: 10.1002/1878-0261.700992021
Research grants (international)
Identifying Genetic, Transcriptional and Microenvironment Drivers of Lethal Prostate Cancer for Better Patient Stratification, Disease Tracking and Drug Target Discovery
2021
Research grants (ARC, NHMRC, MRFF)
Evaluating Clinically Relevant Biomarkers to Improve Early Detection and Treatment of Head and Neck Cancer.
2017
Research Grant
Harnessing Synergies Between 177lutate Therapy and Olaparib to Improve Clinical Outcome of Men With Metastatic Castration Resistant Prostate Cancer
2014
Journal article
Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: A virtual appliance approach for instant deployment
DOI: 10.1371/journal.pone.0095217
RECENT SCHOLARLY WORKS
2024
Journal article
Disruption of metazoan gene regulatory networks in cancer alters the balance of co-expression between genes of unicellular and multicellular origins
DOI: 10.1186/s13059-024-03247-12024
Journal article
Cancer cell-specific PD-L1 expression is a predictor of poor outcome in patients with locally advanced oral cavity squamous cell carcinoma
DOI: 10.1136/jitc-2024-0096172024
Journal article
1616P Circulating tumour DNA (ctDNA) measurements and PET-imaging to evaluate response in a phase Ib trial of metastatic castration-resistant prostate cancer (mCRPC) treated with Lutetium-177-PSMA-617 (LuPSMA) plus pembrolizumab (PRINCE)
DOI: 10.1016/j.annonc.2024.08.16972024
Journal article
Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer
DOI: 10.1002/path.62802024
Journal article
Defining the challenges and opportunities for using patient-derived models in prostate cancer research
DOI: 10.1002/pros.246822024
Journal article
Clonal sweep dynamics: A marker of tumor fitness and predictor of clinical outcomes
DOI: 10.1158/1538-7445.AM2024-22862024
Journal article
Plasma ctDNA enables early detection of temozolomide resistance mutations in glioma
DOI: 10.1093/noajnl/vdae041
RECENT PROJECTS
2020
Research grants (other domestic)
Identifying and Characterising Gene Co-Expression Modules Underlying Resistance to Androgen Deprivation Therapy in Prostate Cancer